Croda International Plc (LON:CRDA - Get Free Report)'s stock price reached a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 2,514 ($33.77) and last traded at GBX 2,526 ($33.93), with a volume of 3758672 shares trading hands. The stock had previously closed at GBX 2,594 ($34.84).
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the company. JPMorgan Chase & Co. raised Croda International to an "overweight" rating in a report on Wednesday, July 30th. Citigroup decreased their price target on Croda International from GBX 3,550 ($47.68) to GBX 3,300 ($44.33) and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Berenberg Bank decreased their price target on Croda International from GBX 3,800 ($51.04) to GBX 3,100 ($41.64) and set a "buy" rating on the stock in a research note on Tuesday, July 29th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on Croda International from GBX 3,400 ($45.67) to GBX 3,000 ($40.30) and set a "hold" rating on the stock in a research note on Tuesday, July 29th.
Read Our Latest Stock Report on CRDA
Croda International Stock Performance
The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. The stock has a market capitalization of £3.43 billion, a PE ratio of 21.07, a P/E/G ratio of 1.40 and a beta of 0.74. The stock has a 50 day moving average of GBX 2,909.22 and a two-hundred day moving average of GBX 2,993.31.
Croda International (LON:CRDA - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported GBX 72.20 ($0.97) EPS for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. Research analysts expect that Croda International Plc will post 181.8307268 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Chris Good purchased 1,000 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was bought at an average cost of GBX 2,633 ($35.37) per share, with a total value of £26,330 ($35,366.02). Also, insider Steve Foots purchased 3,815 shares of the business's stock in a transaction dated Monday, August 4th. The stock was bought at an average cost of GBX 2,617 ($35.15) per share, with a total value of £99,838.55 ($134,101.48). Over the last 90 days, insiders acquired 10,662 shares of company stock valued at $28,237,591. Company insiders own 0.93% of the company's stock.
About Croda International
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Recommended Stories
Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.